Management of the heparin induced thrombocytopenia in the course of acute myocardial infarction
Heparin-induced thrombocytopenia (HIT) is a difficult clinical presentation to deal with and we know little about the management of these patients. Stopping of heparin is essential in treatment but some patients may need anticoagulation in the follow-up; however, we do not have enough data about the...
Main Authors: | Ali Çoner, Sinan Akıncı, Ertan Akbay |
---|---|
Format: | Article |
Language: | English |
Published: |
Alanya Alaaddin Keykubat University
2020-07-01
|
Series: | Acta Medica Alanya |
Subjects: | |
Online Access: | https://dergipark.org.tr/en/pub/medalanya/issue/56070/670263?publisher=alku |
Similar Items
-
Türkiye'nin güneyinde genç hastalarda görülen miyokart enfarktüsü için yeni genetik risk faktörleri
by: Rabia AKILLI EKER, et al.
Published: (2020-03-01) -
Heparin induced thrombocytopenia
by: Yunus Nazlı, et al.
Published: (2014-03-01) -
Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
by: Harry Menon, et al.
Published: (2018-10-01) -
Heparin induced thrombocytopenia type ii and myocardial infarction: Two case reports
by: Antonijević Nebojša, et al.
Published: (2004-01-01) -
Direct Oral Anticoagulants as Successful Treatment of Heparin-Induced Thrombocytopenia: A Parisian Retrospective Case Series
by: Julie Carré, et al.
Published: (2021-08-01)